MYC and melanoma: hPNPase variants lacking both the KH and S1 RNA binding domains or either the RPH1 or the RPH2 domain are still able to degrade c-myc mRNA in vitro and to down-regulate the c-myc mRNA and induce growth arrest in melanoma cells when expressed from an adenoviral vector [85].